Bayer Pharma AG et al v. Dr. Reddys Laboratories, Ltd. et al
| Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. |
| Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. |
| 1:2021cv00732 |
| May 24, 2021 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 13, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint shall be extended from July 15, 2021 to August 16, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod, Eve) |
SO ORDERED, re #11 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Dr. Reddys Laboratories, Inc. answer due 8/16/2021; Dr. Reddys Laboratories, Ltd. answer due 8/16/2021). Signed by Judge Richard G. Andrews on 7/13/2021. (nms)
|
|
SO ORDERED, re #10 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Dr. Reddys Laboratories, Inc. answer due 7/15/2021; Dr. Reddys Laboratories, Ltd. answer due 7/15/2021). Signed by Judge Richard G. Andrews on 6/15/2021. (nms)
|
| Filing 10 STIPULATION TO EXTEND TIME to Answer, Move, Or Otherwise Respond to the Complaint to July 15, 2021 - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Belgam, Neal) |
| Filing 9 SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. Dr. Reddys Laboratories, Ltd. served on 5/25/2021, answer due 6/15/2021. (Blumenfeld, Jack) |
| Filing 8 SUMMONS Returned Executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. Dr. Reddys Laboratories, Inc. served on 5/25/2021, answer due 6/15/2021. (Blumenfeld, Jack) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. - filed by Janssen Pharmaceuticals, Inc. (kmd) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG - filed by Bayer AG, Bayer Pharma AG. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/15/2021. Date of Expiration of Patent: 1/31/2039. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $402, receipt number ADEDC-3621631.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
